Sequence
Tesamorelin
Synthetic 44-residue GHRH analogue with an N-terminal trans-3-hexenoyl group.
- Formula, molecular weight and CAS (where published) listed below
- Cold-packed, plain-packaged, tracked
- Replace or refund if damaged, wrong or not as described
For in-vitro research only. Not a drug, food, supplement or cosmetic, and not for human or veterinary use. Chainwell provides no dosing or usage guidance.
- Sequence
- Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
- Molecular formula
- C221H366N72O67S
- Molecular weight
- 5135.9 g/mol
- CAS
- 218949-48-5
- Form
- Lyophilized powder
Synthetic analogue of human growth hormone–releasing hormone (1–44) amide, N-terminally modified with a trans-3-hexenoyl group (not shown in the sequence). Supplied as a lyophilized powder for in-vitro laboratory research.
No lab report has been published for this compound yet.
Independent third-party testing is on our roadmap. When it starts, every lot's report will be published here.
Store at −20 °C, protected from light. Ships with cold packs. Handle according to good laboratory practice. A safety data sheet is available on request.